Literature DB >> 10777685

Effect of estradiol on neuronal Swedish-mutated beta-amyloid precursor protein metabolism: reversal by astrocytic cells.

B Vincent1, J D Smith.   

Abstract

Alzheimer's disease is the most frequent neurodegenerative disorder in the aged population and is characterized by the deposition of the 40/42-residue amyloid beta protein (Abeta), a proteolytic fragment of the beta-amyloid precursor protein (APP). Recently, it has been shown that physiological doses of estradiol reduce the generation of endogenous Abeta in primary cortical neurons. Here we investigate the influence of estrogen in amyloidogenesis and sAPPalpha secretion in the CNS. By means of primary cortical neurons overexpressing humanized APP(695) bearing the Swedish mutation (hAPP(695sw)), we analyzed APP maturation in the absence or in the presence of estrogen. We show that estrogen at a 2 microM concentration increases the release of the neuroprotective sAPPalpha fragment but does not reduce the release of Abeta in primary neurons overexpressing the Swedish-mutated form of APP. Furthermore, neurons cocultured with astrocytic cells or grown with astrocytes conditioned media do not exhibit the estrogen-induced increase in sAPPalpha secretion. Altogether, our data indicate that astrocytes interfere with estrogen in the regulation of sAPPalpha secretion, probably via secreted factor(s). Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10777685     DOI: 10.1006/bbrc.2000.2581

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

Review 1.  Androgens, aging, and Alzheimer's disease.

Authors:  Christian J Pike; Emily R Rosario; Thuy-Vi V Nguyen
Journal:  Endocrine       Date:  2006-04       Impact factor: 3.633

Review 2.  Protective actions of sex steroid hormones in Alzheimer's disease.

Authors:  Christian J Pike; Jenna C Carroll; Emily R Rosario; Anna M Barron
Journal:  Front Neuroendocrinol       Date:  2009-05-07       Impact factor: 8.606

Review 3.  Drug discovery: estrogen-related compounds in mouse models of Alzheimer's disease.

Authors:  Jonathan D Smith; Enakshi Chakrabarti; Justine A Levin-Allerhand
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

Review 4.  Estrogen and Alzheimer's disease: the story so far.

Authors:  Brenna Cholerton; Carey E Gleason; Laura D Baker; Sanjay Asthana
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

Review 5.  Androgen regulation of beta-amyloid protein and the risk of Alzheimer's disease.

Authors:  Emily R Rosario; Christian J Pike
Journal:  Brain Res Rev       Date:  2007-07-07

Review 6.  Progesterone receptors: form and function in brain.

Authors:  Roberta Diaz Brinton; Richard F Thompson; Michael R Foy; Michel Baudry; Junming Wang; Caleb E Finch; Todd E Morgan; Christian J Pike; Wendy J Mack; Frank Z Stanczyk; Jon Nilsen
Journal:  Front Neuroendocrinol       Date:  2008-02-23       Impact factor: 8.606

Review 7.  Sex hormones, aging, and Alzheimer's disease.

Authors:  Anna M Barron; Christian J Pike
Journal:  Front Biosci (Elite Ed)       Date:  2012-01-01

8.  Gender differences in the relationships among neurosteroid serum levels, cognitive function, and quality of life.

Authors:  Chien-Yu Chen; Chih-Ching Wu; Yu-Chi Huang; Chi-Fa Hung; Liang-Jen Wang
Journal:  Neuropsychiatr Dis Treat       Date:  2018-09-19       Impact factor: 2.570

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.